A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 191,081 shares of PFE stock, worth $5.04 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
191,081
Previous 190,811 0.14%
Holding current value
$5.04 Million
Previous $5.34 Million 3.58%
% of portfolio
0.21%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $7,479 - $8,475
270 Added 0.14%
191,081 $5.53 Million
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $64,968 - $76,131
2,572 Added 1.37%
190,811 $5.34 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $2.03 Million - $2.33 Million
-78,335 Reduced 29.39%
188,239 $5.22 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $2.57 Million - $3.34 Million
-98,334 Reduced 26.95%
266,574 $7.67 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $1.65 Million - $1.92 Million
51,311 Added 16.36%
364,908 $12.1 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $311,354 - $360,229
-8,620 Reduced 2.68%
313,597 $11.5 Million
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $705,356 - $918,270
-17,907 Reduced 5.26%
322,217 $13.1 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $217,642 - $284,108
5,213 Added 1.56%
340,124 $17.4 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $513,698 - $627,097
-11,739 Reduced 3.39%
334,911 $14.7 Million
Q2 2022

Aug 16, 2022

BUY
$46.53 - $55.17 $255,682 - $303,159
5,495 Added 1.61%
346,650 $18.2 Million
Q1 2022

May 17, 2022

SELL
$45.75 - $56.69 $1.13 Million - $1.4 Million
-24,708 Reduced 6.75%
341,155 $17.7 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $49,088 - $72,765
-1,188 Reduced 0.32%
365,863 $21.6 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $154,174 - $198,049
-3,928 Reduced 1.06%
367,051 $15.8 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $305,055 - $345,576
-8,495 Reduced 2.24%
370,979 $14.5 Million
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $3.59 Million - $4.05 Million
107,168 Added 39.36%
379,474 $13.7 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $277,968 - $353,460
8,305 Added 3.15%
272,306 $10 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $1.35 Million - $1.59 Million
-42,640 Reduced 13.91%
264,001 $9.69 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $2.62 Million - $3.18 Million
86,959 Added 39.58%
306,641 $10 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $3 Million - $4.28 Million
-110,856 Reduced 33.54%
219,682 $7.17 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $1.32 Million - $1.5 Million
-40,100 Reduced 10.82%
330,538 $13 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $349,397 - $453,066
10,754 Added 2.99%
370,638 $13.3 Million
Q2 2019

Aug 13, 2019

SELL
$36.98 - $41.52 $1.59 Million - $1.79 Million
-43,008 Reduced 10.67%
359,884 $15.6 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $421,800 - $463,417
-11,248 Reduced 2.72%
402,892 $17.1 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $558,738 - $637,022
-14,524 Reduced 3.39%
414,140 $18.1 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $378,825 - $459,491
10,990 Added 2.63%
428,664 $18.9 Million
Q2 2018

Aug 13, 2018

BUY
$32.98 - $35.16 $789,870 - $842,081
23,950 Added 6.08%
417,674 $15.2 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $402,480 - $466,933
12,613 Added 3.31%
393,724 $14 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $197,231 - $209,269
-5,930 Reduced 1.53%
381,111 $13.8 Million
Q3 2017

Nov 08, 2017

BUY
$31.0 - $34.15 $12 Million - $13.2 Million
387,041
387,041 $13.8 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Meiji Yasuda Asset Management CO Ltd. Portfolio

Follow Meiji Yasuda Asset Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Asset Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Asset Management CO Ltd. with notifications on news.